# clm_1C4BAC822C1D

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_operating_income  
value: -1,291,000 United States dollar  
valid_from: 2009-09-30  
valid_to: 2010-03-31  
published: 2010-10-28  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_802C2C55FF06  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly operating income: -1,291,000 United States dollar", as of 2009-09-30 (until 2010-03-31). Claim clm_1C4BAC822C1D, https://asof.is/claim/clm_1C4BAC822C1D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677410002228/0001206774-10-002228-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2010, filed 2010-10-28  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000120677410002228/0001206774-10-002228-index.htm (primary, SEC EDGAR 10-Q Q3 FY2010, published 2010-10-28)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | -16,266,000 United States dollar | valid 2009-06-30 to 2009-09-30 | conf 0.95 | superseded | superseded_by [clm_1C4BAC822C1D](/claim/clm_1C4BAC822C1D.md) | [clm_B2E1F9844DD6](/claim/clm_B2E1F9844DD6.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.